Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells.

We have investigated the role of Smad family proteins, known to be important cytoplasmic mediators of signals from the transforming growth factor-beta (TGF-beta) receptor serine/threonine kinases, in TGF-beta-dependent differentiation of hematopoietic cells, using as a model the human promyelocytic leukemia cell line, HL-60. TGF-beta-dependent differentiation of these cells to monocytes, but not retinoic acid-dependent differentiation to granulocytes, was accompanied by rapid phosphorylation and nuclear translocation of Smad2 and Smad3. Vitamin D(3) also induced phosphorylation of Smad2/3 and monocytic differentiation; however the effects were indirect, dependent on its ability to induce expression of TGF-beta1. Simultaneous treatment of these cells with TGF-beta1 and all-trans-retinoic acid (ATRA), which leads to almost equal numbers of granulocytes and monocytes, significantly reduced the level of phospho-Smad2/3 and its nuclear accumulation, compared with that in cells treated with TGF-beta1 alone. TGF-beta1 and ATRA activate P42/44 mitogen-activated protein (MAP) kinase with nearly identical kinetics, ruling out its involvement in these effects on Smad phosphorylation. Addition of the inhibitor-of-protein serine/threonine phosphatases, okadaic acid, blocks the ATRA-mediated reduction in TGF-beta-induced phospho-Smad2 and shifts the differentiation toward monocytic end points. In HL-60R mutant cells, which harbor a defective retinoic acid receptor-alpha (RAR-alpha), ATRA is unable to reduce levels of TGF-beta-induced phospho-Smad2/3, coincident with its inability to differentiate these cells along granulocytic pathways. Together, these data suggest a new level of cross-talk between ATRA and TGF-beta, whereby a putative RAR-alpha-dependent phosphatase activity limits the levels of phospho-Smad2/3 induced by TGF-beta, ultimately reducing the levels of nuclear Smad complexes mediating the TGF-beta-dependent differentiation of the cells to monocytic end points.

[1]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[2]  J. Eisman,et al.  Cross-talk between 1,25-Dihydroxyvitamin D3 and Transforming Growth Factor-β Signaling Requires Binding of VDR and Smad3 Proteins to Their Cognate DNA Recognition Elements* , 2001, The Journal of Biological Chemistry.

[3]  K. Miyazono,et al.  Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. , 2001, Molecular biology of the cell.

[4]  M. D. de Caestecker,et al.  Transcriptional Cross-talk between Smad, ERK1/2, and p38 Mitogen-activated Protein Kinase Pathways Regulates Transforming Growth Factor-β-induced Aggrecan Gene Expression in Chondrogenic ATDC5 Cells* , 2001, The Journal of Biological Chemistry.

[5]  Xuening Wang,et al.  Activation of extracellular signal‐regulated kinases (ERKs) defines the first phase of 1,25‐dihydroxyvitamin D3‐induced differentiation of HL60 cells , 2001, Journal of cellular biochemistry.

[6]  A. Hata.  TGFβ Signaling and Cancer , 2001 .

[7]  R. Weinberg,et al.  Ski/Sno and TGF-β signaling , 2001 .

[8]  Edward S. Kim,et al.  Immunohistochemical expression of smads 1–6 in the 15‐day gestation mouse embryo: signaling by BMPs and TGF‐βs † , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[9]  A. Balmain,et al.  TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest , 2000 .

[10]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[11]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.

[12]  G. Adler,et al.  TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation , 2000, Oncogene.

[13]  G. Gabriëls,et al.  Involvement of protein phosphatases in differential regulation of renal proximal tubular PAH and sodium‐dependent dicarboxylate transport * , 2000, Fundamental & clinical pharmacology.

[14]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Reiner,et al.  1α,25-Dihydroxyvitamin D3–Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3-Kinase Signaling Complex , 1999, The Journal of experimental medicine.

[16]  Y. Y. Lee,et al.  Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor. , 1999, Leukemia research.

[17]  K. Miyazono,et al.  Region between α‐helices 3 and 4 of the Mad homology 2 domain of Smad4: functional roles in oligomer formation and transcriptional activation , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[18]  J. Massagué,et al.  Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.

[19]  R. Derynck,et al.  Regulation of Smad signalling by protein associations and signalling crosstalk. , 1999, Trends in cell biology.

[20]  C. Day,et al.  Inhibition of rat hepatocyte proliferation by transforming growth factor β and glucagon is associated with inhibition of ERK2 and p70 S6 kinase , 1999, Hepatology.

[21]  J. Dick,et al.  Bone Morphogenetic Proteins Regulate the Developmental Program of Human Hematopoietic Stem Cells , 1999, The Journal of experimental medicine.

[22]  J. Massagué,et al.  A Smad Transcriptional Corepressor , 1999, Cell.

[23]  J. Massagué,et al.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.

[24]  K. Kishi,et al.  Involvement of SHP‐1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell lines , 1999, European journal of haematology.

[25]  K. Miyazono,et al.  Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.

[26]  T. Commes,et al.  Transforming growth factor‐β1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids , 1999, Journal of cellular physiology.

[27]  H. Drexler,et al.  Growth-inhibitory effects of transforming growth factor-β1 on myeloid leukemia cell lines , 1998 .

[28]  A. Yen,et al.  Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. , 1998, Cancer research.

[29]  A. Roberts,et al.  Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. , 1998, Genes & development.

[30]  D. J. Van Den Berg,et al.  The Smad5 Gene Is Involved in the Intracellular Signaling Pathways That Mediate the Inhibitory Effects of Transforming Growth Factor-β on Human Hematopoiesis , 1998 .

[31]  T. Yoshida,et al.  Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin. , 1997, Cytokine.

[32]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[33]  M. Mumby,et al.  The interconversion of protein phosphatase 2A between PP2A1 and PP2A0 during retinoic acid-induced granulocytic differentiation and a modification on the catalytic subunit in S phase of HL-60 cells. , 1997, Archives of biochemistry and biophysics.

[34]  C. Mathieu,et al.  Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-β 2 and their combinations , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  F. Ruscetti,et al.  Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[36]  D. Danielpour.  Induction of transforming growth factor‐β autocrine activity by all‐trans‐retinoic acid and 1α,25‐dihydroxyvitamin D3 in NRP‐152 rat prostatic epithelial cells , 1996 .

[37]  H. Drexler,et al.  Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. , 1995, Leukemia research.

[38]  M. Nagao,et al.  Decreased expression of protein phosphatase type 2A in HL-60 variant (HL-60RAr) cells resistant to induction of cell differentiation by all-trans retinoic acid. , 1995, Experimental hematology.

[39]  M. Mumby,et al.  Expression of the catalytic and regulatory subunits of protein phosphatase type 2A may be differentially modulated during retinoic acid-induced granulocytic differentiation of HL-60 cells. , 1994, Cancer research.

[40]  S. Jacobsen,et al.  The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors. , 1994, Experimental hematology.

[41]  John Calvin Reed,et al.  Progression of the myeloid differentiation program is dominant to transforming growth factor-beta 1-induced apoptosis in M1 myeloid leukemic cells. , 1994, Blood.

[42]  M. Kasuga,et al.  Phorbol ester stimulates the activity of a protein tyrosine phosphatase containing SH2 domains (PTP1C) in HL-60 leukemia cells by increasing gene expression. , 1993, The Journal of biological chemistry.

[43]  T. Kuno,et al.  Down‐regulation by retinoic acid of the catalytic subunit of protein phosphatase type 2A during granulocytic differentiation of HL‐60 cells , 1993, FEBS letters.

[44]  C. Peschle,et al.  Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines. , 1993, Journal of immunology.

[45]  K. Robertson,et al.  Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. , 1992, Blood.

[46]  K. Robertson,et al.  Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells , 1992, Molecular and cellular biology.

[47]  F. Ruscetti,et al.  Induction of transforming growth factor-beta 1 (TGF-beta 1), receptor expression and TGF-beta 1 protein production in retinoic acid-treated HL-60 cells: possible TGF-beta 1-mediated autocrine inhibition. , 1991, Blood.

[48]  F. Ruscetti,et al.  Synergy between transforming growth factor-beta and tumor necrosis factor-alpha in the induction of monocytic differentiation of human leukemic cell lines , 1990 .

[49]  J. Bonner,et al.  Differentiation , 1968, Nature.

[50]  A. Hata.  TGFbeta signaling and cancer. , 2001, Experimental cell research.

[51]  R. Weinberg,et al.  Ski/Sno and TGF-beta signaling. , 2001, Cytokine & growth factor reviews.

[52]  E. Sontag.  Protein phosphatase 2A: the Trojan Horse of cellular signaling. , 2001, Cellular signalling.

[53]  A. Balmain,et al.  TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. , 2000, Genes & development.

[54]  J. Massagué.  How cells read TGF-beta signals. , 2000, Nature reviews. Molecular cell biology.

[55]  R. Frey,et al.  Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. , 1999, Oncogene.

[56]  J. Massagué,et al.  Ubiquitin-dependent degradation of TGF-beta-activated smad2. , 1999, Nature cell biology.

[57]  D. J. Van Den Berg,et al.  The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. , 1998, Blood.

[58]  H. Drexler,et al.  Growth-inhibitory effects of transforming growth factor-beta 1 on myeloid leukemia cell lines. , 1998, Leukemia research.

[59]  K. Miyazono,et al.  Smad6 inhibits signalling by the TGF-beta superfamily. , 1997, Nature.

[60]  D Falb,et al.  The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. , 1997, Cell.

[61]  G. Andersson,et al.  Adhesion of human myelomonocytic (HL-60) cells induced by 1,25-dihydroxyvitamin D3 and phorbol myristate acetate is dependent on osteopontin synthesis and the alpha v beta 3 integrin. , 1996, Connective tissue research.

[62]  D. Danielpour.  Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. , 1996, Journal of cellular physiology.

[63]  G. Andersson,et al.  Adhesion of Human Myelomonocytic (HL-60) Cells Induced by 1, 25-dihydroxyvitamin D3 and Phorbol Myristate Acetate is Dependent on Osteopontin Synthesis and the αvβ3 Integrin , 1996 .